Single User License
INR 134643
Site License
INR 269285
Corporate User License
INR 403928

Service Tax Additional

select a format
Price

Single User License
USD 1995
Site License
USD 3990
Corporate User License
USD 5985

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Philippines

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Philippines


  Request for Sample Report

Executive Summary

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Philippines

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Philippines". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

In 2015, Philippines population was approximately at 100.9 million. The government of Philippines has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country's future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The Philippines pharmaceutical market is the third-largest pharmaceutical market in the Association of Southeast Asian Nations (ASEAN), after Indonesia and Thailand. The Pharmaceutical market was estimated to be worth USD 3.4 billion in 2015 and expected to reach USD 4.1 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.7% over the 2008-2020 period. The medical device market was valued at USD 400m in 2008 and is expected to reach approximately USD 600m by 2020, at a projected CAGR of 8.1%.

These positive trends can primarily be attributed to

An increasing elderly population in Philippines, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices

Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Philippines, and includes

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck Co.)

An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the Philippines healthcare market

Reasons To Buy

This report will enhance your decision-making capability by allowing you to

Develop business strategies by understanding the trends shaping and driving Philippines healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Identify, understand, and capitalize on the opportunities and challenges in Philippines healthcare market

1 Table of Contents

1 Table of Contents 6

1.1 List of Tables 9

1.2 List of Figures 12

2 Introduction 16

2.1 GlobalData Report Guidance 16

3 Overview of Pharmaceutical and Medical Device Market 17

3.1 Pharmaceutical Market 17

3.1.1 Market Overview 17

3.1.2 Pharmaceutical Exports and Imports 21

3.1.3 Supply Channels 22

3.1.4 Market Segments 23

3.1.5 Overview of Major Disease Areas 25

3.1.6 Major Players 28

3.2 Medical Device Market 67

3.2.1 Market Overview 67

3.3 Market Drivers and Barriers 67

3.3.1 Drivers 67

3.3.2 Barriers 68

4 Market Access 70

4.1 Reimbursement and Payer Landscape 70

4.1.1 Overview of Healthcare System 70

4.1.2 Reimbursement Process 71

4.1.3 Overview of Insurance Providers 75

4.1.4 Patient Share in Healthcare Spending 80

4.1.5 Price Trends in the Healthcare Sector 82

4.1.6 Pricing Policies 83

4.2 Regulatory Landscape 84

4.2.1 Overview of Regulatory Agencies 84

4.2.2 Market Authorization Procedure for Pharmaceutical Products 85

4.2.3 New Medical Device Approval Process 91

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 91

4.2.5 Exports and Imports 92

4.2.6 Intellectual Property Rights 95

4.2.7 Clinical Trial Regulations 99

4.2.8 Pharmaceutical Advertising Regulations 102

4.2.9 Pharmacy Regulations 103

4.2.10 Labeling and Packaging Regulations 104

5 Country Analysis 106

5.1 Political Environment 106

5.1.1 Political Structure 106

5.1.2 Analysis of Current Political Environment 107

5.1.3 Healthcare Policy Initiatives 108

5.2 Economic Landscape 113

5.3 Economic Indicators 118

5.3.1 Gross Domestic Product 118

5.3.2 Gross National Income 122

5.3.3 Inflation 123

5.3.4 Currency Exchange Rate 125

5.3.5 Foreign Direct Investment 126

5.3.6 Foreign Exchange Reserves 127

5.3.7 Trade Balance 128

5.3.8 Fiscal Deficit 130

5.3.9 General Government Gross Debt 131

5.3.10 External Debt 132

5.3.11 Major Industries 133

5.4 Demographics 136

5.4.1 Population 136

5.4.2 Education and Literacy 153

5.4.3 Employment 155

5.4.4 Disease Burden 156

5.5 Healthcare Infrastructure 159

5.5.1 Healthcare Facilities 159

5.5.2 Healthcare Parameters 164

5.5.3 Environmental Health 165

5.5.4 Healthcare Personnel 167

5.6 Healthcare Expenditure 170

5.6.1 Overview 170

5.6.2 Major Components of Healthcare Spending 171

5.6.3 Share of Public and Private Sector 172

5.6.4 Spending in Pharmaceutical R&D 173

5.7 Trade Associations 173

5.7.1 Pharmaceutical and Healthcare Association of the Philippines 173

5.7.2 The Philippine Pharmaceutical Manufacturers Association 173

5.7.3 The Philippine Pharmacist Association 173

5.7.4 The Philippine Medical Association 174

5.8 Trade Fairs 174

6 Opportunities and Challenges 175

6.1 Opportunities 175

6.2 Challenges 175

7 Appendix 178

7.1 Abbreviations 178

7.2 Bibliography 181

7.3 Research Methodology 196

7.3.1 Coverage 196

7.3.2 Secondary Research 196

7.3.3 Forecasts 197

7.3.4 Expert Panel 197

7.4 Disclaimer 198

1.2 List of Figures

Figure 1: Pharmaceutical Market, Philippines, Revenue (USD bn), 2008-2015 19

Figure 2: Pharmaceutical Market, Philippines, Revenue Forecast (USD bn), 2016-2020 20

Figure 3: Pharmaceutical Market, Philippines, Exports and Imports (USD m), 2008-2014 21

Figure 4: Pharmaceutical Distribution Channel, Philippines, Distribution Share (%), 2008 22

Figure 5: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008 23

Figure 6: Healthcare Market, Philippines, Drivers and Barriers, 2016 69

Figure 7: Healthcare Market, Philippines, Healthcare System, 2016 70

Figure 8: Healthcare Market, Philippines, Drug Selection Procedure for Philippine National Drug Formulary, 2016 73

Figure 9: Healthcare Market, Philippines, Reimbursement Process, 2016 74

Figure 10: Healthcare Market, Philippines, PhilHealth Milestones, 2016 77

Figure 11: Membership in PhilHealth, Philippines, Sector Share (%), 2016 78

Figure 12: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016 79

Figure 13: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015 81

Figure 14: Price of Healthcare Products, Philippines, Change in Average Price of Health Sector (%), 2008-2014 82

Figure 15: Healthcare Market, Philippines, Food and Drug Administration Structure, 2014 85

Figure 16: Philippines, Healthcare Market, Approval Process of New Drugs and Medical Devices, 2014 88

Figure 17: Healthcare Market, Philippines, Approval Process of Generic Drugs, 2016 90

Figure 18: Healthcare Market, Philippines, Bureau of Health Devices and Technology Structure, 2016 91

Figure 19: Healthcare Market, Philippines, Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, 2016 92

Figure 20: Healthcare Market, Philippines, Patent Approval Process, 2016 97

Figure 21: Healthcare Market, Philippines, Trademark Approval Process, 2016 98

Figure 22: Healthcare Market, Philippines, Clinical Trial Approval Process, 2014 101

Figure 23: Healthcare Market, Philippines, Procedure for Opening a Retail Pharmacy, 2014 103

Figure 24: Healthcare Policy Initiatives, Philippines, Major Healthcare Reforms, 1999-2014 112

Figure 25: Economic Indicators, Philippines, Gross Domestic Product per Capita (USD ), 2008-2015 118

Figure 26: Economic Indicators, Philippines, Gross Domestic Product per Capita (USD ), 2016-2020 119

Figure 27: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015 120

Figure 28: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020 121

Figure 29: Economic Indicators, Philippines, Gross National Income per Capita (USD ), 2008-2014 122

Figure 30: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013 123

Figure 31: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013 124

Figure 32: Economic Indicators, Philippines, Currency Exchange Rate (PHP/USD ), 2008-2015 125

Figure 33: Economic Indicators, Philippines, Foreign Direct Investment (USD bn), 2008-2014 126

Figure 34: Economic Indicators, Philippines, Foreign Exchange Reserves (USD bn), 2008-2014 127

Figure 35: Economic Indicators, Philippines, Imports of Goods and Services (USD bn), 2008-2015 128

Figure 36: Economic Indicators, Philippines, Exports of Goods and Services (USD bn), 2008-2015 129

Figure 37: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014 130

Figure 38: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015 131

Figure 39: Economic Indicators, Philippines, External Debt (USD bn), 2008-2015 132

Figure 40: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added (USD bn), 2013-2014 133

Figure 41: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added (USD bn), 2013-2014 134

Figure 42: Demographics, Philippines, Population (million), 2008-2015 136

Figure 43: Demographics, Philippines, Population (million), 2016-2020 137

Figure 44: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015 138

Figure 45: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020 139

Figure 46: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015 140

Figure 47: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020 141

Figure 48: Demographics, Philippines, Births (per 1,000 population), 2008-2014 142

Figure 49: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014 143

Figure 50: Demographics, Philippines, Major Causes of Mortality (000), 2013 144

Figure 51: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015 145

Figure 52: Demographics, Philippines, Immunization Rate (%), 2008-2014 146

Figure 53: Demographics, Philippines, Major Causes of Male Mortality (000), 2013 147

Figure 54: Demographics, Philippines, Major Causes of Female Mortality (000), 2013 149

Figure 55: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014 150

Figure 56: Demographics, Philippines, Gender Ratio (M/F), 2008-2014 151

Figure 57: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015 152

Figure 58: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020 153

Figure 59: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014 154

Figure 60: Demographics, Philippines, Unemployment Rate (%), 2008-2015 155

Figure 61: Demographics, Philippines, Major Diseases, Morbidity (000), 2013 156

Figure 62: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009 158

Figure 63: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014 160

Figure 64: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014 161

Figure 65: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 162

Figure 66: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009 163

Figure 67: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014 164

Figure 68: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014 166

Figure 69: Environmental Health, Philippines, PM2.5 (g/m), 2008-2014 167

Figure 70: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014 168

Figure 71: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014 169

Figure 72: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014 170

Figure 73: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013 171

Figure 74: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014 172

Figure 75: Healthcare Market, Philippines, Opportunities and Challenges, 2016 177

1.1 List of Tables

Table 1: Pharmaceutical Market, Philippines, Revenue (USD bn), 2008-2015 20

Table 2: Pharmaceutical Market, Philippines, Revenue Forecast (USD bn), 2016-2020 20

Table 3: Pharmaceutical Market, Philippines, Exports and Imports (USD m), 2008-2014 21

Table 4: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008 23

Table 5: Pfizer, Global, Major Products, Revenue (USD bn) and Annual Growth (%), 2015 34

Table 6: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016 35

Table 7: GlaxoSmithKline, Global, Major Products Revenue (USD m) and Annual Growth (%), 2015 42

Table 8: Pharmaceutical Market, GlaxoSmithKline, Late-Stage Pipeline, 2016 43

Table 9: Novartis, Global, Major Products, Revenue (USD bn) and Annual Growth (%), 2015 50

Table 10: Pharmaceutical Market, Novartis, Planned Filings, 2014-2018 51

Table 11: Merck & Co., Global, Major Products, Revenue (USD bn) and Annual Growth (%), 2015 59

Table 12: Pharmaceutical Market, Global, Late-Stage Pipeline, Merck & Co., 2016 60

Table 13: Membership in PhilHealth, Philippines, Sector Share (%), 2016 78

Table 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016 79

Table 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015 81

Table 16: Price of Healthcare Products, Philippines Change in Average Price of Health Sector (%), 2008-2014 82

Table 17: Economic Indicators, Philippines, Gross Domestic Product per Capita (USD ), 2008-2015 118

Table 18: Economic Indicators, Philippines, Gross Domestic Product per Capita (USD ), 2016-2020 119

Table 19: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015 120

Table 20: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020 121

Table 21: Economic Indicators, Philippines, Gross National Income per Capita (USD ), 2008-2014 122

Table 22: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013 123

Table 23: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013 124

Table 24: Economic Indicators, Philippines, Currency Exchange Rate (PHP/USD ), 2008-2015 125

Table 25: Economic Indicators, Philippines, Foreign Direct Investment (USD bn), 2008-2014 126

Table 26: Economic Indicators, Philippines, Foreign Exchange Reserves (USD bn), 2008-2014 127

Table 27: Economic Indicators, Philippines, Imports of Goods and Services (USD bn), 2008-2015 128

Table 28: Economic Indicators, Philippines, Exports of Goods and Services (USD bn), 2008-2015 129

Table 29: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014 130

Table 30: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015 131

Table 31: Economic Indicators, Philippines, External Debt (USD bn), 2008-2015 132

Table 32: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added (USD bn), 2012-2013 134

Table 33: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added (USD bn), 2013-2014 135

Table 34: Demographics, Philippines, Population (million), 2008-2015 136

Table 35: Demographics, Philippines, Population (million), 2016-2020 137

Table 36: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015 138

Table 37: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020 139

Table 38: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015 140

Table 39: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020 141

Table 40: Demographics, Philippines, Births (per 1,000 population), 2008-2014 142

Table 41: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014 143

Table 42: Demographics, Philippines, Major Causes of Mortality (000), 2013 144

Table 43: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015 146

Table 44: Demographics, Philippines, Immunization Rate (%), 2008-2014 147

Table 45: Demographics, Philippines, Major Causes of Male Mortality (000), 2013 148

Table 46: Demographics, Philippines, Major Causes of Female Mortality (000), 2013 149

Table 47: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014 150

Table 48: Demographics, Philippines, Gender Ratio (M/F), 2008-2014 151

Table 49: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015 152

Table 50: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020 153

Table 51: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014 154

Table 52: Demographics, Philippines, Unemployment Rate (%), 2008-2015 155

Table 53: Demographics, Philippines, Major Diseases, Morbidity (000), 2013 157

Table 54: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009 159

Table 55: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014 160

Table 56: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014 161

Table 57: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 162

Table 58: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009 163

Table 59: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014 164

Table 60: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014 166

Table 61: Environmental Health, Philippines, PM2.5 (g/m), 2008-2014 167

Table 62: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014 168

Table 63: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014 169

Table 64: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014 170

Table 65: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013 171

Table 66: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014 172

Table 67: Healthcare Market, Philippines, Major Trade Fairs, 2016 174

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Pharmaceutical market, Medical device market, Reimbursement landscape, Regulatory landscape, Country analysis, Drivers and barriers, Opportunities and challenges


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com